Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?

BACKGROUND: Patients with tunneled central venous lines (CVL) may develop bloodstream infections which at times are difficult to control without line removal. Concomitant severe thrombocytopenia with platelet transfusion refractoriness is often considered a major contraindication to any procedure in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marwah, Priya, Ramprakash, Stalin, Prasad T R, Sai, Gizhlaryan, Mane, Trivedi, Deepa, Shah, Vaibhav, Chitaliya, Amit, Elizabeth, Sandeep, Agarwal, Rajat Kumar, Dhanya, Rakesh, Faulkner, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BMT and Cellular Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175805/
https://www.ncbi.nlm.nih.gov/pubmed/35846206
http://dx.doi.org/10.1002/jha2.379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175805/
https://www.ncbi.nlm.nih.gov/pubmed/35846206
http://dx.doi.org/10.1002/jha2.379

Ejemplares similares